Statements (37)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:disease
autoimmune disease neurological disorder |
| gptkbp:affects |
central nervous system
|
| gptkbp:cause |
fatigue
muscle weakness cognitive impairment numbness vision problems coordination difficulties |
| gptkbp:characterizedBy |
inflammation
demyelination |
| gptkbp:diagnosedBy |
neurological examination
MRI lumbar puncture |
| gptkbp:firstDescribed |
gptkb:Jean-Martin_Charcot
|
| https://www.w3.org/2000/01/rdf-schema#label |
Disseminated Sclerosis
|
| gptkbp:ICD-10_code |
G35
|
| gptkbp:MeSH_ID |
D009103
|
| gptkbp:OMIM |
126200
|
| gptkbp:onset |
usually between ages 20 and 40
|
| gptkbp:prevalence |
more common in women
more common in temperate climates |
| gptkbp:riskFactor |
gptkb:Epstein-Barr_virus_infection
smoking genetic predisposition vitamin D deficiency |
| gptkbp:subspecies |
gptkb:secondary_progressive_multiple_sclerosis
relapsing-remitting multiple sclerosis primary progressive multiple sclerosis progressive-relapsing multiple sclerosis |
| gptkbp:synonym |
gptkb:Multiple_Sclerosis
|
| gptkbp:treatment |
physical therapy
corticosteroids immunomodulatory drugs |
| gptkbp:bfsParent |
gptkb:D009290
|
| gptkbp:bfsLayer |
8
|